Enable AccessibilityEnable Accessibility

Transparency Reporting

Takeda Pharmaceuticals Australia Pty Ltd has undertaken to be open and transparent in its interactions with the community in which it operates.  As a member of Medicines Australia, we publish the details of reportable payments or transfers of value to healthcare professionals.  Reportable payments or transfers of value are:

  • Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant;
  • Airfares, accommodation and/or conference registration fees provided as part of services as above, or to attend medical education.

Takeda Pharmaceuticals Australia Pty Ltd prepares reports for publication in accordance with the Medicines Australia Code of Conduct and Australia’s Privacy legislation. The reports for expenditure prior to 1 October 2016 identify healthcare professionals by name where their consent has been provided. Where consent has not been provided the information is reported in aggregate.

From 1 October 2016, reporting these payments is mandatory – details will be reported because healthcare professionals should reasonably expect that all reportable payments or transfers of value will be disclosed for each healthcare professional, by name.

From 30 August 2019, the information included in the 1 November 2018 – 30 April 2019 report and all future reports will be available in a database, administered by Medicines Australia for those healthcare professionals who have been informed that this information will be published in this database. This database is designed to be searchable and can be downloaded as a CSV file.

For further information about the details in the report, or to search the database, please visit www.DisclosureAustralia.com.au

To comply with our privacy obligations, the reports may be amended from time to time. The reports here contain the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, which must comply with the Australian Privacy Act 1988.

 

Takeda Pharmaceuticals Australia Pty Ltd

Click here for November 2018 – April 2019 PDF

Click here for November 2018 – April 2019 CSV

 

Click here for May 2018 - October 2018 PDF

Click here for May 2018 - October 2018 CSV

 

Click here for Nov 2017 - April 2018 PDF

Click here for Nov 2017 - April 2018 CSV

 

Click here for May 2017 - October 2017 PDF

Click here for May 2017 - October 2017 CSV

 

Click here for November 2016 - April 2017 PDF 

Click here for November 2016 - April 2017 CSV 

 

Shire Australia Pty Ltd 

Click here for November 2018 – April 2019 PDF

Click here for November 2018 – April 2019 CSV

 

Click here for May 2018 - October 2018 PDF

Click here for May 2018 - October 2018 CSV

 

Click here for Nov 2017 - April 2018 PDF

Click here for Nov 2017 - April 2018 CSV

 

Click here for May 2017 - October 2017 PDF

Click here for May 2017 - October 2017 CSV

 

Click here for November 2016 - April 2017 PDF 

Click here for November 2016 - April 2017 CSV

 

All reports will be available for at least three years from the date of publication.